Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include YISAIPU, a tumor necrosis factor inhibitor type II-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Septin, an injection for anti-human epidermal growth factor receptor-2 treatment;… Read more
Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.016x
Based on the latest financial reports, Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) has a cash flow conversion efficiency ratio of 0.016x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥89.72 Million) by net assets (CN¥5.66 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sunshine Guojian Pharmaceutical Shanghai Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Sunshine Guojian Pharmaceutical Shanghai Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sunshine Guojian Pharmaceutical Shanghai Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sunshine Guojian Pharmaceutical Shanghai Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TI FLUID SYSTEMS LS-01
F:TI1
|
N/A |
|
Montrose Environmental Grp
NYSE:MEG
|
0.061x |
|
Enghouse Systems Limited
PINK:EGHSF
|
0.023x |
|
CREDITACCESS GRAMEEN LIMITED
NSE:CREDITACC
|
0.043x |
|
Henan Senyuan Electric Co Ltd
SHE:002358
|
-0.002x |
|
Turkiye Vakiflar Bankasi TAO
IS:VAKBN
|
-0.347x |
|
Ningbo Tech-Bank Co Ltd
SHE:002124
|
0.051x |
|
Empire State Realty Trust Inc
NYSE:ESRT
|
0.059x |
Annual Cash Flow Conversion Efficiency for Sunshine Guojian Pharmaceutical Shanghai Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Sunshine Guojian Pharmaceutical Shanghai Co Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.54 Billion | CN¥281.14 Million | 0.051x | -40.51% |
| 2023-12-31 | CN¥4.88 Billion | CN¥416.35 Million | 0.085x | +68.12% |
| 2022-12-31 | CN¥4.60 Billion | CN¥233.49 Million | 0.051x | +194.52% |
| 2021-12-31 | CN¥4.54 Billion | CN¥-243.79 Million | -0.054x | -505.77% |
| 2020-12-31 | CN¥4.52 Billion | CN¥-40.08 Million | -0.009x | -104.38% |
| 2019-12-31 | CN¥2.90 Billion | CN¥587.64 Million | 0.202x | +83.51% |
| 2018-12-31 | CN¥3.28 Billion | CN¥361.28 Million | 0.110x | +36.79% |
| 2017-12-31 | CN¥2.92 Billion | CN¥235.11 Million | 0.081x | -42.01% |
| 2016-12-31 | CN¥2.55 Billion | CN¥354.35 Million | 0.139x | +2.45% |
| 2015-12-31 | CN¥2.47 Billion | CN¥335.69 Million | 0.136x | +13.35% |
| 2014-12-31 | CN¥2.21 Billion | CN¥264.01 Million | 0.120x | -13.98% |
| 2013-12-31 | CN¥1.99 Billion | CN¥276.41 Million | 0.139x | -38.73% |
| 2012-12-31 | CN¥1.54 Billion | CN¥349.54 Million | 0.227x | +21.36% |
| 2011-12-31 | CN¥1.28 Billion | CN¥239.71 Million | 0.187x | +8.47% |
| 2010-12-31 | CN¥1.05 Billion | CN¥181.81 Million | 0.173x | -30.99% |
| 2009-12-31 | CN¥665.80 Million | CN¥166.48 Million | 0.250x | +33.22% |
| 2008-12-31 | CN¥523.99 Million | CN¥98.35 Million | 0.188x | +196.63% |
| 2007-12-31 | CN¥463.64 Million | CN¥29.34 Million | 0.063x | +208.00% |
| 2006-12-31 | CN¥444.77 Million | CN¥-26.06 Million | -0.059x | -- |